𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cognitive correlates of cortical cholinergic denervation in Parkinson’s disease and parkinsonian dementia

✍ Scribed by N. I. Bohnen; D. I. Kaufer; R. Hendrickson; L. S. Ivanco; B. J. Lopresti; G. M. Constantine; Ch. A. Mathis; J. G. Davis; R. Y. Moore; S. T. DeKosky


Publisher
Springer
Year
2005
Tongue
English
Weight
218 KB
Volume
253
Category
Article
ISSN
0340-5354

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Cognitive correlates of visual hallucina
✍ Kolbjorn Bronnick; Murat Emre; Sibel Tekin; Siri B. Haugen; Dag Aarsland 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 1 views

## Abstract ## Background: There may be a relationship between cognitive impairment and visual hallucinations (VHs) in patients with Parkinson's disease (PD). The objective of this study was to compare the cognitive profile of hallucinating vs. nonhallucinating patients with Parkinson's disease de

Cognitive impairment and dementia in Par
✍ Karen Marder 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 1 views

## Abstract Over the last decade, the importance of cognitive impairment and dementia in Parkinson's disease (PDD) has been increasingly recognized. Investigators have proposed criteria for PD dementia, and mild cognitive impairment. Risk profiles associated with the development of dementia based o

Cholinergic and other neurotransmitter m
✍ Paul T. Francis; Elaine K. Perry 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

It is now 30 years since the beginning of intensive efforts to understand the neurotransmitter biochemistry of dementia as exemplified by Alzheimer's disease and such studies have led to the development of rational treatment strategies, which are continuing to benefit patients. However, as studies b

Prevalence and correlates of neuropsychi
✍ Jaime Kulisevsky; Javier Pagonabarraga; Berta Pascual-Sedano; Carmen García-Sánc 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB 👁 1 views

## Abstract A cross‐sectional study of the profile of psychiatric symptoms and their relationships to medications, executive performance, and excessive daytime somnolence (EDS) was conducted on 1351 consecutive Parkinson's disease patients without dementia (PD‐ND). Ratings were: neuropsychiatric in